Placebo News and Research

RSS

Data establishes safety profile of new GlaxoSmithKline rotavirus vaccine candidate

Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.

6 Jan 2006

Rotateq eliminates the most severe cases of rotavirus

In a study of more than 68,000 infants published in the New England Journal of Medicine, the investigational vaccine Rotateq demonstrated that it can safely prevent 98 percent of severe cases of viral diarrhea and vomiting that account for 2 million hospital visits and 500,000 pediatric deaths each year worldwide.

6 Jan 2006

Clarithromycin reduces recurrent cardiovascular events in patients without periodontitis

Periodontitis, an infection of the gingiva and tooth-supporting tissues, may influence the effectiveness of antibiotics used for the prevention of recurrent cardiovascular events.

5 Jan 2006

Vertebroplasty reduces back pain and increases activity levels

A Mayo Clinic study has found patients report less back pain at rest and while active following vertebroplasty, a procedure in which medical cement is injected into painful compression fractures in the spinal vertebrae due to osteoporosis. Patients also reported improved function in their daily activities, such as walking, housework and getting dressed. The findings are published in the November/December issue of American Journal of Neuroradiology.

30 Dec 2005

Post cardiac surgery heart irregularities reduced by medication

Use of the medication amiodarone is associated with one-half the incidence of atrial tachyarrhythmias (rapid, abnormal heart beat) following cardiac surgery, according to a study in the December 28 issue of JAMA.

28 Dec 2005

Women suffering lupus OK to take oral contraceptives

Major study of women with either inactive or stable systemic lupus erythematosus (lupus) – a disease in which the body's immune system mistakenly attacks and damages healthy tissues of the skin, joints and internal organs – were able to take oral contraceptives without increased risk of flares, or periods of increased disease activity, that characterize the disease.

22 Dec 2005

Erection problems may signal heart disease

According to a new study, men who complain of erection problems, have a higher risk of heart attack, stroke, and angina.

22 Dec 2005

Earlier hormone therapy trial scared women - but it was wrong!

According to new research the widely publicised 2002 study which apparently proved that hormone replacement therapy raised the risk of heart disease and breast cancer, was fundamentally flawed.

19 Dec 2005

Lupus patients safe to go back on the pill

Two new studies confirm that women who suffer from lupus, a chronic disease that can lead to inflamed kidneys, can safely take oral contraceptives without fear that the pill will worsen their condition.

19 Dec 2005

FDA panel approves vaccine for shingles

According to an FDA advisory panel, studies show that an experimental vaccine to prevent shingles can cut the rate of infection by about half in people 60 and older and help curb related pain.

19 Dec 2005

Milk thistle extract treatment for liver disease found to be ineffective

Results of high-quality randomized clinical trials have determined that milk thistle extract, a widely used alternative medication, may not have any significant influence on the course of patients with alcoholic liver disease or hepatitis B or C liver disease.

15 Dec 2005

Chronic pain sufferers may be able to reduce pain levels by studying their own live brain images

Chronic pain sufferers may be able to reduce pain levels by studying their own live brain images, researchers at the Stanford University School of Medicine report in a new study.

15 Dec 2005

Heart drug designed for U.S. blacks a cheaper option

According to researchers a new heart-failure drug designed especially for blacks could reduce the amount it costs to treat the disease by as much as 34 percent.

14 Dec 2005

More good news - Femara helps prevent the return of breast cancer

In more good news for women suffering from breast cancer a study by the the Swiss drugmaker Novartis has shown that their drug Femara benefits women with hormone-sensitive early breast cancer.

14 Dec 2005

It's all in the mind so think that pain away

According to U.S. researchers chronic discomfort can be reduced by brain manipulation and people in chronic pain can "think away" their suffering by learning to manipulate the activity of the brain.

14 Dec 2005

Stress increases alcoholism

A number of sociocultural studies indicate that stress may increase the risk of alcoholism. In other words, an individual's ability to cope with stressful situations may indicate his or her vulnerability to alcoholism.

13 Dec 2005

Testosterone replacement therapy shows promise for Alzheimer sufferers

The first study of the effects of testosterone on mood, behavior and psychological health in men with mild Alzheimer disease finds significant improvements in quality of life, as assessed by caregivers.

13 Dec 2005

Perimenopause critical for preventing heart disease and osteoporosis

Research in monkeys suggests that the perimenopause - the five to 10 years before a woman's menopause - is a critical time for preventing heart disease and osteoporosis.

13 Dec 2005

New treatment for chronic Immune Thrombocytopenic Purpura

Data from a Phase II study of eltrombopag, an oral investigational drug that increases the production of platelets, demonstrate that the compound was effective in increasing platelet counts in patients with chronic Immune Thrombocytopenic Purpura (ITP), a disorder characterized by episodes of frequent spontaneous bruising, mucosal bleeding, and in severe cases intracranial hemorrhage, and acute episodes of severe bleeding.

12 Dec 2005

Alagebrium may prevent arterial aging in patients with systolic hypertension

A compound called alagebrium, which is very similar to another used in anti-wrinkle creams, may be useful in reducing the deleterious effects of arterial aging in the majority of elderly Americans with systolic hypertension, a new study from researchers at Johns Hopkins shows.

5 Dec 2005